Currently out of the existing stock ratings of Gregory Renza, 135 are a BUY (79.88%), 34 are a HOLD (20.12%).

Gregory Renza

Work Performance Price Targets & Ratings Chart

Analyst Gregory Renza works at RBC with a stock forecast success ratio of 34.17% fulfilled within 113.39 days on average.

Gregory Renza’s has documented 332 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRMD, CorMedix at 13-Mar-2024.

Wall Street Analyst Gregory Renza

Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $111 was fulfilled within 1 day with a profit of $15.2 (15.87%) receiving and performance score of 158.66.

Average potential price target upside

ACAD ACADIA Pharmaceuticals APRE Aprea Therapeutics APTO Aptose Biosciences AVTX Avalo Therapeutics BLU BELLUS Health . GMDA Gamida Cell Ltd INO Inovio Pharmaceuticals ITRM Iterum Therapeutics PLC MORF Morphic XNCR Xencor GBT Global Blood Therapeutics SGEN Seagen ADCT ADC Therapeutics SA RXDX Prometheus Biosciences VRCA Verrica Pharmaceuticals JAZZ Jazz Pharmaceuticals PLC AMGN Amgen IDYA Ideaya Biosciences LIFE aTyr Pharma NRIX Nurix Therapeutics  NUVB Nuvation Bio PRVB Provention Bio SPRB Spruce Biosciences  VIRX Viracta Therapeutics VSTM Verastem ARQL ArQule ALPN Alpine Immune Sciences CRMD CorMedix EXEL Exelixis PCRX Pacira Pharmaceuticals VRDN Viridian Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

25

$7.2 (40.45%)

29

28 days ago

5/8 (62.5%)

$7.16 (40.13%)

26

Buy

30

$12.2 (68.54%)

40

1 months 9 days ago

16/19 (84.21%)

$10.44 (53.37%)

184

Buy

39

$21.2 (119.10%)

40

1 months 25 days ago

6/10 (60%)

$15.25 (64.21%)

94

Buy

33

$15.2 (85.39%)

33

1 months 25 days ago

8/19 (42.11%)

$9.25 (38.95%)

119

Buy

36

$18.2 (102.25%)

1 months 25 days ago

0/1 (0%)

$12.25 (51.58%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Gregory Renza is most bullish on?

Potential upside of $79.91 has been obtained for JAZZ (JAZZ PHARMACEUTICALS PLC)

Which stock is Gregory Renza is most reserved on?

Potential downside of -$9.53 has been obtained for ALPN (ALPINE IMMUNE SCIENCES)

What Year was the first public recommendation made by Gregory Renza?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?